A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B.

ABSTRACT: Hepatitis B virus (HBV) infection remains a global public problem despite the availability of an effective vaccine. In the past decades, nonalcoholic fatty liver disease (NAFLD) has surpassed HBV as the most common cause of chronic liver disease worldwide. The prevalence of concomitant chronic hepatitis B (CHB) and NAFLD thus reaches endemic proportions in geographic regions where both conditions are common. Patients with CHB and NAFLD are at increased risk of liver disease progression to cirrhosis and hepatocellular carcinoma. Due to the complexity of the pathogenesis, accurate diagnosis of NAFLD in CHB patients can be challenging. Liver biopsy is considered the gold standard for diagnosing and determining disease severity, but it is an invasive procedure with potential complications. The

SUBMITTER: Hanif H 

PROVIDER: S-EPMC7601829 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature